methylglucamine antimoniate
Small moleculeexperimental
Clinical trial activity
9 trials · 18 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
3
Phase 4
1
Earliest trial started Sep 1, 1995 (NCT00004755)
Timeline
Indications
Approved for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
- Mol. weight
- 365.98 g/mol
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL239129 ↗
Also known as
- 1-deoxy-1- (methylamino)glucitol antimonate(v)
- glucantime
- glucantime
- meglumine antimonate
- meglumine antimonate
- meglumine antimonate
- meglumine antimonate
- meglumine antimoniate
- meglumine antimoniate
- meglumine antimoniate
- meglumine antimoniate
- meglumine antimony
- methylglucamine antimonate
- n-methylglucamine antimonate
- n-methylglucamine antimoniate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01464242 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2011 | Centro Internacional de Entrenamiento e Investigaciones Médicas |
| NCT01310738 | Phase 4 | Feb 1, 2011 | Conselho Nacional de Desenvolvimento Científico e Tecnológico, Drugs for Neglected Diseases Initiative, Federal University of Minas Gerais, Federal University of Piaui, Federal University of Sergipe, Government of Brazil, Hospital Infantil Joao Paulo II - FHEMIG, State University of Montes Claros, University of Brasilia |
| NCT01377974 | Phase 2 | Jul 1, 2009 | University of Brasilia |
| NCT00682656 | Phase 2/Phase 3 (Phase 3) | Jun 1, 2008 | Conselho Nacional de Desenvolvimento Científico e Tecnológico, Drugs for Neglected Diseases Initiative, Oswaldo Cruz Foundation |
| NCT00480883 | N/A | Jan 1, 2008 | Pakistan Army |
| NCT00600548 | Phase 2 | Jul 1, 2007 | AEterna Zentaris, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Federal University of Bahia, Government of Spain |
| NCT00469495 | N/A | Feb 1, 2007 | Federal University of Bahia |
| NCT00471705 | Phase 3 | Jun 1, 2006 | Universidad de Antioquia |
| NCT00004755 | Phase 2 | Sep 1, 1995 | Harvard University, National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (18)
18 organizations
Page 1 / 1